Why are new drugs and cheaper, more user friendly regimes needed?

Slides:



Advertisements
Similar presentations
Pulmonary Tuberculosis.
Advertisements

Tuberculosis in Afghanistan Photography by: Riccardo Venturi Presented by: World Health Organization Regional Office for the Eastern Mediterranean 2007.
The Re- emerging Threat of TB Magnitude of the Problem Associated Factors & challenges Current strategies Aamod Asmita Dr. Bala Dr. Arun Dr. Samraj Nisha.
The Work of WHO in the South-East Asia Region Report of the Regional Director 1 July 2008–31 August 2009 Highlights of the Work of in the South-East.
Renewing Health Canada’s strategy against TB for First Nations on-reserve Provincial Primary Care Tuberculosis Education Day October 28, 2011 Presented.
M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
Introduction India has the highest burden of tuberculosis in the world, with an estimated 2 million cases annually, accounting for 1/5 th of global incidence.
High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa – Implications for HIV and TB Treatment Programs Kogieleum Naidoo on behalf.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
TB Drug Co-Development Roundtable: TMC207 (bedaquiline) Chrispin Kambili, M.D. CPTR meeting Oct 04, To edit footers: "insert tab>header and footer"
COMMISSION FOR CHILDREN WITH SPECIAL HEALTH CARE NEEDS Your child, ___________________________, has passed the hearing evaluation completed on ________________________.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
Health Professional Students AIDS Advocacy Network Treat the People: Access to Essential AIDS Medications A Primer for Health Professional Students.
What, Where, How and Action Steps… XDR-TB
October 3, Serial Testing of Health Care Workers for Tuberculosis Using Interferon-γ Assay Madhukar Pai, et. al. American Journal of Respiratory.
Bird Flu A threat to Insurance? Henk van Broekhoven.
Molecular methods for TB drug resistance testing: what is needed? Experience from Khayelitsha, Cape Town, South Africa Helen Cox, PhD, Burnet Institute.
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa.
The Lilly MDR-TB Partnership Local Action, Global Impact World Bank Donor Forum Paris, France 20 May 2008 Patrizia Carlevaro Head, International Aid Unit.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Multi-drug resistant tuberculosis: Progress and challenges in South Africa Dr S. Moyo HIV/AIDS, Sexually Transmitted Infections and TB research (HAST)Programme.
A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,
Three key messages on tuberculosis control World Tuberculosis Day 2010 ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March.
Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.
Tuberculosis Research of INA-RESPOND on Drug-resistant
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps…
Epidemiology of tuberculosis. Peymane Adab, Richard Fielding, Susana Castan.
Max O’Donnell, Nesri Padayatchi, Iqubal Master, Garth Osburn, Robert Horsburgh Treatment of Extensively Drug Resistant Tuberculosis Among Patients with.
Ecdc.europa.eu Tommi Asikainen, Tubingen, 22 October 2008 European Centre for Disease Prevention and Control FUTURE DISEASE CHALLENGES IN EUROPE – where.
World Health Assembly 63 Geneva, Suisse May 2010 WORLD HEALTH EDITORS NETWORK Tracking Global Health News: building health literacy Multi-Drug Resistant.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Division of Tuberculosis Elimination Centers for Disease Control and Prevention Tuberculosis in the United States National Tuberculosis Surveillance System.
Homework 2 Part I: Drug Resistance and the Three Great Pandemics.
Module 2 - Epidemiology of Tuberculosis
Missouri Department of Health and Senior Services Bureau of Communicable Disease Control TB Control Program.
International Health Policy Program -Thailand Policy decision on multi drug resistant(MDR), extreme drug resistant(XDR) tuberculosis screening: How it.
Epidemiologic Studies Consortium Research CTCA meeting October 22, 2010 Lisa Pascopella, PhD, MPH California Department of Health Services.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Beyond Sputum Cups and Four Drugs The Responsibility of the Practicing Clinician in the Community Control of Tuberculosis V. R. Koppaka, MD, PhD Division.
Epidemiology of Tuberculosis in African-American Population, United States Kenneth G. Castro, M.D. Assistant Surgeon General, USPHS Director,
Public Health. TB-DOTS program Government commitment Case detection by DSSM among symptomatic patients self-reporting to health services Standard short-course.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Mario C. Raviglione, M.D. Director, Stop TB Department WHO, Geneva, Switzerland TB prevention, care and control, : Framing global and WHO strategic.
Abstract Modern chemotherapy has played a major role in our control of tuberculosis. Yet tuberculosis still remains a leading infectious disease worldwide.
Improving the tuberculosis control using the Directly Observed Treatment programme in Limpopo Province, South Africa 4 th International Conference on Nursing.
James R. Ginder, MS, WEMT,PI, CHES Health Education Specialist Jeremy D. Hamilton Health Education Intern Hamilton County Health Department
Innovative Strategies for Addressing Hepatitis C in Indian Country March 14, 2016.
Global Tuberculosis Control 2007 Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?
Measures to Decrease TB Prevalence in the Barents Region Andrey O. Maryandyshev Elena I. Nikishova Dmitry V. Perkhin.
Ch Epidemiology Microbiology.
TB-HIV Last updated: January 2017.
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
2.4a Boosting your immunity
CAPRISA Advanced Clinical Care Presented by: Nesri Padayatchi
Tailored Review Proposal for Tuberculosis
Nazir Ismail CTB/NICD & WHO-SRL & UP
Tuberculosis in the United States
اپيدميولوژي و كنترل سِل
TB-HIV Last updated: March 2018.
Evidence for use of urinary LAM
Presentation 1 Introduction
TB-HIV Last updated: November 2018.
Key issues in DOTS implementation
Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002–11, and requirements.
L. Zhang, Q. Meng, S. Chen, M. Zhang, B. Chen, B. Wu, G. Yan, X
World TB Day Bradley Allen, MD, PhD, Medical Consultant
Drug Resistance and the Three Great Pandemics
Volume 375, Issue 9728, Pages (May 2010)
A Time of Commitments and Actions to accelerate action to End TB
Presentation transcript:

Why are new drugs and cheaper, more user friendly regimes needed?

"Tuberculosis, whether caused by drug-susceptible or drug-resistant strains, rarely made even medical headlines, in part because its importance as a cause of death continued to decline in areas in which headlines are written.” Keshavjee and Farmer, NEJM, 2012* And what TB crisis? * Tuberculosis, Drug Resistance, and the History of Modern Medicine. Salmaan Keshavjee and Paul Farmer. N Engl J Med. 2012 Sep 6;367(10):931-6.

Cost-ineffective? “…selective primary health care and ‘cost-effectiveness’ have shaped an anemic response to the ongoing global pandemic.”* *Tuberculosis, Drug Resistance, and the History of Modern Medicine. Salmaan Keshavjee and Paul Farmer. N Engl J Med. 2012 Sep 6;367(10):931-6.

Slide courtesy: Prof Keertan Dheda

SA : MDR-TB already >55% of TB budget! Financing the scale-up of MDR-TB prevention and Treatment. Katherine Floyd, Stop TB, WHO. Ministerial meeting. Beijing, China, 2009 http://www.who.int/tb_beijingmeeting/media/press_pack/presentations/day2_presentation3.pdf

The perception among the majority is that we are not at risk of being infected by TB. This assumption is deeply flawed. Dr Madhukar Pai, India Tribune, 29 October 2012 The RNTCP needs to think beyond treatment of drug-resistant TB, and focus on preventing a major epidemic. In the case of drug-resistant TB, an ounce of prevention is definitely better than a pound of cure http://www.tribuneindia.com/2012/20121029/edit.htm#6

Care for the carer ±1/100: number of South Africans diagnosed with TB last year (WHO, 2012). 3x: increased rate of TB among Health Care Workers globally (Baussano, 2011). 6.3%: confirmed drug-resistance among occupational TB cases at Tygerberg Hospital (Data: 2008-2011). 5.56x higher incidence rate of MDR- and XDR (O’Donnell, 2010) Means 3/100 HCW’s could be diagnosed with TB every year At least 1/16 could have MDR-TB or worse

Lucky and thankful… Dalene got her life back, she can still hear, and can even practice as a clinician again…what next? TB PROOF

Start at the beginning:

2nd Year Medical Students

Anyone can get TB Nobel peace prize TB survivors “UBUNTU” – I am because we are We are all in this together! http://www.health24.com/tools/Slideshows/1891-4704-4775,61850.asp

SA record: 114m in one breath! HOPE: Life after TB SA record: 114m in one breath!

Thank you! Physicians: Paul Willcox CBTBR/Genetics: Gerhard Walzl Andreas Diacon Simon Schaaf Tony Biebuyck Jantjie Taljaard Keertan Dheda Pharmacology Gary Maartens Elsimé Kift Jeannine Du Bois Supportive Justus Apffelstaedt - Surgery Mou Manie - Rheumatology Anton Doubell - Cardiology Mark Abelson – Cardiology Prof Loock – Ear, nose and throat Radiology Sucari Vlok Arthur Maydall Jan Lotz Occupational Health/TBH Jack Meintjies Sr Samuels Sr Arendse Matodzi Mukosi - super Elmarie Malek Mariana Kruger SAMA - Daniel Madiba CBTBR/Genetics: Gerhard Walzl Belinda Kriel Daleen Kriel Rob Warren Tommie Victor Soraya Bardien-Kruger Lizma Streicher Tibotec/Janssen: David McNeeley Gilles van Baar NHLS Mariza Hoffman Haematology and Microbiology Technologists Audiology: Rene Visagie Sharon Pithey Tygerberg Audiologists CAPRISA Nesri Padayatchi Kogieleum Naidoo TB PROOF Angela Dramowski Bart Willems Heena Narotam Helene-Mari van der Westhuizen Koot Kotze Treatment Action Group Thank you!

“The momentum to break this disease is in real danger “The momentum to break this disease is in real danger. We are now at a crossroads between TB elimination within our lifetime, and millions more TB deaths.”  Dr Mario Raviglione; Director of the WHO Stop TB Department; 17 October 2012 Questions?